期刊文献+

血清AFP、CA125、CA199联合检测在原发性肝癌中的诊断价值 被引量:12

The value of serum AFP,CA125,CA199 combined detection in the diagnosis of hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨血清AFP、CAl25、CAl99联合检测在原发性肝癌中的诊断价值。方法入选病例主要为我院2011年1月~2013年1月收治病例,其中肝癌组28例,良性肝病组30例,另选择同期健康体检者32例作为对照组。比较各组患者的AFP、CAl25、CAl99水平,比较各组检测的阳性率及联合检测的阳性率。结果原发性肝癌组患者血清AFP、CAl25、CAl99水平均分别明显高于良性肝病组和对照组(P〈0.01)。其中良性肝病组患者AFP、CAl25、CAl99水平分别明显高于对照组(P〈0.01)。肝癌组的AFP、CAl25、CAl99阳性率及联合检测阳性率均分别明显高于对照组(尺0.05)。其中良性肝病组患者AFP、CAl25、CAl99阳性率及联合检测阳性率分别明显高于对照组(P〈0.01)。结论血清AFP、CAl25、CAl99联合检测弥补了单项指标检测的不足,明显提高了诊断的阳性率,减少了漏诊率,为肝癌的诊断和治疗提供了指导依据。 Objective To investigate the value of AFP,CA125,CA199 in the diagnosis of primary liver cancer. Methods Selected 28 cases of HCC,30 cases of benign liver disease group,32 cases of healthy people as control group,the AFP, CA125, CA199 levels and the positive rate were compared. Results The levels of serum AFP, CA125, CA199 levels in HCC were significantly higher than those of benign liver disease group and the control group (P〈0.01). The AFP,CA125 ,CA199 levels of benign liver disease patients were significantly higher than the control group (P〈0.01). The AFP, CA125, CA199 positive rate of HCC group and combined detection were significantly higher than the control group (P〈0.05). Which AFP, CA125, CA199 positive rate of benign liver disease patients and combined detection were significantly higher(P〈0.01 ). Conclusion Serum AFP,CA125 ,CA199 joint detection up for the lack of detection of in- dividual indicators,significantly improve the diagnostic positive rate,reduce the rate of misdiagnosis,diagnosis and treatment of liver cancer provides a basis for guiding.
出处 《中国现代医生》 2014年第1期61-62,共2页 China Modern Doctor
关键词 原发性肝癌 AFP CA125 CA199 阳性率 I-ICC AFP CA 125 CA 199 Positive rate
  • 相关文献

参考文献8

二级参考文献35

共引文献68

同被引文献83

  • 1王嘉倍,刘连新.肝细胞癌生物标志物的研究进展[J].世界华人消化杂志,2005,13(18):2251-2256. 被引量:34
  • 2Urban N,Thorpe JD,Bergan LA,et al. Potential role of HE4 in multimodal screening for epithelial ovarian cancer [J]. J Natl Cancer Inst ,2011,103 (21) : 1630-1634.
  • 3Lenhard M,Stieber P, Hertlein L,et al. The diagnostic accu- racy of two human epididymisprotein 4 (HE4)testing sys- tems in combination with CA125 in the differential diag- nosis of ovarian masses [J]. Clin Chem Lab Med,2011,49 (12) : 2081-2088.
  • 4Lawicki S,Bedkowska GE,Gacuta-Szumarska E,et aL The plasma concentration of VEGF,HE4 and CA125 as a new biomarkers panel in different stages and sub-types of ep- ithelialovarian tumors [J]. J Ovarian Res,2013,6(1):45.
  • 5Macuks R,Baidekalna I,Donina S. An ovarian cancer ma- lignancy risk index composed of HE4,CA125,uhrasono- graphic score, and menopausal status:use in differentiation of ovarian cancers and benign lesions [J]. Tumour Biol, 2012,33(5) : 1811-1817.
  • 6Montagnana M,Danese E,Ruzzenente O,et al. The ROMA (risk of ovarian malignancy algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass:is it really useful? [J]. Clin Chem Lab Med, 2011,49(3) :521-525.
  • 7Anastasi E,Granato T,Fatzarano R,et al. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian- cancer [J]. J Ovarian Res ,2013,6(1 ) :44.
  • 8Hamed EO,Ahmed H,Sedeek OB,et al. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response [J]. Diagn Pathol, 2013,8 : 11.
  • 9Kim YM, Whang DH, Park J, et al. Evaluation of the ac- curacy of serum human epididymisprotein 4 in combina- tion with CA125 for detecting ovariancancer:a prospec- tive case-control study in a Korean population [J]. Clin Chem Lab Med,2011,49(3) :527-534.
  • 10Hirokawa F,Hayashi M,Miyamoto Y,et al.Surgical out-comes and clinical characteristics of elderly patients un-dergoing curative hepatectomy for hepatocellular carcino-ma[J].J Gastrointest Surg,2013,17(11):1929-1937.

引证文献12

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部